| Application number | Title of the application | Filing Date | Status |
|---|
Array
(
[id] => 4088489
[patent_doc_number] => 06025481
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2000-02-15
[patent_title] => 'Isolated nucleic acid molecules which encode human anti-Lewis b antibodies'
[patent_app_type] => 1
[patent_app_number] => 9/080554
[patent_app_country] => US
[patent_app_date] => 1998-05-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 8898
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 26
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/025/06025481.pdf
[firstpage_image] =>[orig_patent_app_number] => 080554
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/080554 | Isolated nucleic acid molecules which encode human anti-Lewis b antibodies | May 17, 1998 | Issued |
| 09/080027 | INHIBITION OF ANGIOGENESIS | May 14, 1998 | Abandoned |
Array
(
[id] => 1479470
[patent_doc_number] => 06451979
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-09-17
[patent_title] => 'Methods of treatment using NBS-1, antibodies and proteins thereto, and uses of the antibodies'
[patent_app_type] => B1
[patent_app_number] => 09/081975
[patent_app_country] => US
[patent_app_date] => 1998-05-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 20
[patent_figures_cnt] => 39
[patent_no_of_words] => 14565
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 30
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/451/06451979.pdf
[firstpage_image] =>[orig_patent_app_number] => 09081975
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/081975 | Methods of treatment using NBS-1, antibodies and proteins thereto, and uses of the antibodies | May 11, 1998 | Issued |
| 09/069725 | PROTEINS ASSOCIATED WITH EGF SIGNALING | Apr 28, 1998 | Abandoned |
Array
(
[id] => 4173388
[patent_doc_number] => 06140470
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2000-10-31
[patent_title] => 'Human monoclonal anti-tumor antibodies'
[patent_app_type] => 1
[patent_app_number] => 8/983607
[patent_app_country] => US
[patent_app_date] => 1998-04-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20347
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 52
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/140/06140470.pdf
[firstpage_image] =>[orig_patent_app_number] => 983607
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/983607 | Human monoclonal anti-tumor antibodies | Apr 26, 1998 | Issued |
Array
(
[id] => 4406739
[patent_doc_number] => 06309816
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-10-30
[patent_title] => 'Methods for diagnosing cancer by measuring creatine kinase'
[patent_app_type] => 1
[patent_app_number] => 9/060703
[patent_app_country] => US
[patent_app_date] => 1998-04-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 2227
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 88
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/309/06309816.pdf
[firstpage_image] =>[orig_patent_app_number] => 060703
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/060703 | Methods for diagnosing cancer by measuring creatine kinase | Apr 14, 1998 | Issued |
Array
(
[id] => 4411577
[patent_doc_number] => 06300476
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-10-09
[patent_title] => 'Anti-peptide antibody against human cytochrome P450 3A4'
[patent_app_type] => 1
[patent_app_number] => 9/057897
[patent_app_country] => US
[patent_app_date] => 1998-04-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 14
[patent_no_of_words] => 11233
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 48
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/300/06300476.pdf
[firstpage_image] =>[orig_patent_app_number] => 057897
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/057897 | Anti-peptide antibody against human cytochrome P450 3A4 | Apr 8, 1998 | Issued |
Array
(
[id] => 4158686
[patent_doc_number] => 06103873
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2000-08-15
[patent_title] => 'Isolated renal cancer specific antigen'
[patent_app_type] => 1
[patent_app_number] => 9/053453
[patent_app_country] => US
[patent_app_date] => 1998-04-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 7362
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 21
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/103/06103873.pdf
[firstpage_image] =>[orig_patent_app_number] => 053453
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/053453 | Isolated renal cancer specific antigen | Mar 31, 1998 | Issued |
Array
(
[id] => 4307352
[patent_doc_number] => 06241985
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-06-05
[patent_title] => 'Method and composition for reconforming multi-epitopic antigens to initiate an immune response'
[patent_app_type] => 1
[patent_app_number] => 8/913290
[patent_app_country] => US
[patent_app_date] => 1998-03-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 10724
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 110
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/241/06241985.pdf
[firstpage_image] =>[orig_patent_app_number] => 913290
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/913290 | Method and composition for reconforming multi-epitopic antigens to initiate an immune response | Mar 19, 1998 | Issued |
Array
(
[id] => 4186676
[patent_doc_number] => 06150508
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2000-11-21
[patent_title] => 'Monoclonal antibodies specific for the extracellular domain of prostate-specific membrane antigen'
[patent_app_type] => 1
[patent_app_number] => 9/044668
[patent_app_country] => US
[patent_app_date] => 1998-03-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 20
[patent_figures_cnt] => 24
[patent_no_of_words] => 17430
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 33
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/150/06150508.pdf
[firstpage_image] =>[orig_patent_app_number] => 044668
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/044668 | Monoclonal antibodies specific for the extracellular domain of prostate-specific membrane antigen | Mar 17, 1998 | Issued |
Array
(
[id] => 876847
[patent_doc_number] => 07358347
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2008-04-15
[patent_title] => 'MEN1, the gene associated with multiple endocrine neoplasia type 1, menin polypeptides and uses thereof'
[patent_app_type] => utility
[patent_app_number] => 09/380337
[patent_app_country] => US
[patent_app_date] => 1998-03-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 22062
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 10
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/358/07358347.pdf
[firstpage_image] =>[orig_patent_app_number] => 09380337
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/380337 | MEN1, the gene associated with multiple endocrine neoplasia type 1, menin polypeptides and uses thereof | Mar 3, 1998 | Issued |
| 09/032369 | CHIMERIC CELL-SURFACE RECEPTORS THAT UNDERGO ANTIGEN-INDUCED ASSOCIATION | Feb 26, 1998 | Abandoned |
| 09/030298 | NOVEL MULTITARGET DRUGS AND THERAPEUTIC APPLICATIONS | Feb 24, 1998 | Abandoned |
| 09/030579 | HUMAN C-MAF COMPOSITIONS AND METHODS OF USE THEREOF | Feb 23, 1998 | Abandoned |
Array
(
[id] => 4306811
[patent_doc_number] => 06326464
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-12-04
[patent_title] => 'P53 protein variants and therapeutic uses thereof'
[patent_app_type] => 1
[patent_app_number] => 8/983035
[patent_app_country] => US
[patent_app_date] => 1998-02-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 19
[patent_no_of_words] => 33199
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 12
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/326/06326464.pdf
[firstpage_image] =>[orig_patent_app_number] => 983035
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/983035 | P53 protein variants and therapeutic uses thereof | Feb 19, 1998 | Issued |
Array
(
[id] => 4330494
[patent_doc_number] => 06320022
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-11-20
[patent_title] => 'Adrenomedullin peptides'
[patent_app_type] => 1
[patent_app_number] => 9/011922
[patent_app_country] => US
[patent_app_date] => 1998-02-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 26
[patent_figures_cnt] => 76
[patent_no_of_words] => 21519
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 19
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/320/06320022.pdf
[firstpage_image] =>[orig_patent_app_number] => 011922
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/011922 | Adrenomedullin peptides | Feb 16, 1998 | Issued |
| 09/025012 | HAPTEN-MODIFIED TUMOR CELL MEMBRANES AND METHODS OF MAKING AND USING HAPTEN-MODIFIED TUMOR CELL MEMBRANES | Feb 16, 1998 | Abandoned |
| 08/973603 | HAPTEN MODIFIED TUMOR CELL EXTRACT AND METHODS OF TREATING OR SCREENING FOR CANCER | Feb 12, 1998 | Abandoned |
Array
(
[id] => 4141228
[patent_doc_number] => 06063379
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2000-05-16
[patent_title] => 'Anti-idiotypic monoclonal antibodies and compositions including the anti-idiotypic monoclonal antibodies'
[patent_app_type] => 1
[patent_app_number] => 9/015540
[patent_app_country] => US
[patent_app_date] => 1998-01-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 4865
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 59
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/063/06063379.pdf
[firstpage_image] =>[orig_patent_app_number] => 015540
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/015540 | Anti-idiotypic monoclonal antibodies and compositions including the anti-idiotypic monoclonal antibodies | Jan 28, 1998 | Issued |
Array
(
[id] => 4146234
[patent_doc_number] => 06138680
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2000-10-31
[patent_title] => 'Method for destroying retinal pigment epithelial cells'
[patent_app_type] => 1
[patent_app_number] => 9/014492
[patent_app_country] => US
[patent_app_date] => 1998-01-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2992
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 151
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/138/06138680.pdf
[firstpage_image] =>[orig_patent_app_number] => 014492
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/014492 | Method for destroying retinal pigment epithelial cells | Jan 27, 1998 | Issued |